Posted on April 13, 2019 by Sitemaster
Some data presented a few weeks ago at the annual meeting of the European Association for Urology appear to have surprised not only the study’s authors, but pretty much everyone else as well. … READ MORE …
Filed under: Uncategorized | Tagged: low risk, replacement, serum, surgery, testosterone, TRT | 6 Comments »
Posted on March 21, 2019 by Sitemaster
Conventional wisdom (dating back to the 1940s) has long been that giving testosterone supplements to men who had been treated for prostate cancer is a really bad idea. … READ MORE …
Filed under: Uncategorized | Tagged: hypogonadal, replacement, serum, testosterone, TRT | 4 Comments »
Posted on November 15, 2017 by Sitemaster
Discussions about the pros and cons of testosterone replacement therapy (TRT) in relation to (a) stimulating risk for prostate cancer in men who have not been diagnosed and (b) recurrence of prostate cancer among men who have been diagnosed and treated often aren’t entirely clear about a very key factor. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypogonadism, replacement, risk, serum, testosterone, TRT | 18 Comments »
Posted on March 16, 2017 by Sitemaster
A new article in the Journal of Clinical Oncology has further undermined the long-held belief that there was an inherently increased risk for prostate cancer among men who received treatment with testosterone replacement therapy (TRT) for low testosterone levels. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, replacement, risk, testosterone, therapy, TRT | 7 Comments »
Posted on September 13, 2016 by Sitemaster
As we have mentioned frequently before, the use of testosterone replacement therapy (TRT) in men diagnosed with and/or treated for prostate cancer has been highly controversial, and the data supporting a role for TRT in such patients has been limited. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: hypogonadism, replacement, testosterone, therapy, TRT | 2 Comments »
Posted on November 17, 2015 by Sitemaster
We may be seeing the beginning of a real turning point in opinions about the role of testosterone replacement therapy (TRT) in men who have been treated for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cancer, hypogonadal, replacement, testosterone, TRT | 3 Comments »
Posted on October 27, 2015 by Sitemaster
Many urologists these days are fairly comfortable prescribing testosterone replacement therapy (TRT) for men who have had a radical prostatectomy and whose PSA has stayed at undetectable levels for some time. However, … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: radiation, replacement, testosterone, TRT | 2 Comments »
Posted on November 26, 2014 by Sitemaster
A new paper in the Journal of Urology provides data from European males with clinically low levels of serum testosterone indicating that, in these patients, testosterone replacement therapy (TRT) was not associated with any increase in risk for a diagnosis of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypogonadism, replacement, testosterone, TRT | 10 Comments »
Posted on October 14, 2014 by Sitemaster
The “New” Prostate Cancer InfoLink has long argued that the use of testosterone supplements by otherwise healthy men as they age (as a way to try to maintain the vigor and libido of their youth) comes with risks, and that one of those risks is the risk for a diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: age, risk, supplement, testosterone, TRT | 7 Comments »
Posted on July 22, 2013 by Sitemaster
The role of supplemental testosterone therapy in men previously treated for prostate cancer has long been a controversial issue, and the number of patients actually studied for the effects of such therapy (good and bad) is really quite small — at about 600 worldwide. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypogonadism, outcome, radical prostatectomy, risk, testosterone, TRT | 13 Comments »
Posted on March 19, 2013 by Sitemaster
A new paper just published in the Journal of Urology addresses (again) the controversial issue of whether the use of testosterone replacement therapy (TRT) is appropriate as a management strategy after first-line treatment for hypogonadal patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypogonadism, radical prostatectomy, replacement, risk, surgery, testosterone, TRT | 3 Comments »
Posted on December 7, 2009 by Sitemaster
There continues to be controversy over the role of testosterone replacement therapy (TRT) in men with prostate cancer who are “hypogonadal” — i.e., men with very low testosterone levels — as a consequence of their treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: testosterone replacement, TRT | 1 Comment »
Posted on April 18, 2009 by Sitemaster
Today’s news reports deal with:
- Active surveillance management strategies and outcomes to date
- Life expectancy and the appropriateness of treatment
- Penile rehabilitation post-surgery
- Testosterone replacement therapy in prostate cancer patients … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, life expectancy, penile rehabilitation, testosterone replacement, Treatment, TRT | Leave a comment »
Posted on March 10, 2009 by Sitemaster
Today’s news reports include items on:
- Risk for prostate cancer
- Patient decisions about sexual functionality and prostate cancer treatment
- Whole gland and focal cryotherapy
- Testosterone replacement after prostate cancer therapy
and other items. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a comment »
Posted on February 11, 2009 by Sitemaster
Today’s news reports contain four key items:
- A review of the potential of phytochemicals in treatment of prostate cancer
- A Norwegian study on correlation between biopsy-based and post-surgical Gleason scores
- A retrospective study on risk for prostate cancer in men being treated with testosterone replacement therapy
- An announcement of new data on PSP94 in the diagnosis of prostate cancer … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, Gleason score, Miraculins, phytochemicals, PSP94, testosterone replacement, TRT | Leave a comment »